Perinatal infections can arise before, during, or soon after birth, and different organisms have different screening, transmission, treatment, and newborn-response questions. A useful legal review identifies the specific infection and the information available at each time instead of applying one rule to every pregnancy.

An infection during pregnancy or around delivery is not itself proof that screening, treatment, communication, or newborn care was negligent.

Identify the infection and the relevant time period

  • The organism or suspected organism, test method, specimen, collection time, preliminary and final result, susceptibility information, and any corrected result
  • Prenatal, intrapartum, congenital, and postnatal transmission possibilities identified by the treating and reviewing clinicians
  • Maternal symptoms, risk factors, prior results, medications, allergies, prenatal visits, labor events, membrane status, fever, and delivery information
  • Newborn examination, cultures and other testing, symptoms, treatment, consultations, imaging, discharge, readmission, and later diagnosis

Check the current screening guidance that fits the infection

CDC guidance states that clinicians should screen during each pregnancy for group B streptococcus and explains the role of late-pregnancy results in reducing early newborn disease. The current group B strep screening page identifies the recommended screening period and why results may change over time.

CDC also publishes pregnancy screening guidance for HIV, hepatitis B, hepatitis C, and syphilis. Its separate perinatal hepatitis B testing guidance addresses screening during each pregnancy, maternal results, newborn prevention steps, and later testing.

These sources are starting points for clinical review, not a verdict. Guidance date, patient risk, gestational timing, earlier results, access to care, contraindications, test performance, and the actual event circumstances must be considered.

Map the result and response across teams

  • Who ordered the test, who received each result, how urgency was marked, and whether the result reached prenatal, labor, delivery, nursery, pediatric, and follow-up teams
  • What treatment or prevention was considered, ordered, administered, declined, delayed, changed, or not indicated, with the documented reason
  • Whether new symptoms or risk information changed the plan and when consultation, escalation, delivery, transfer, or newborn evaluation occurred
  • Which communication, handoff, portal, laboratory, pharmacy, medication, and administration records confirm the sequence

Prove the causal difference

The reviewer should distinguish maternal infection, fetal or newborn infection, inflammation, prematurity, congenital condition, and later complications. A claim needs a qualified explanation of what different care probably would have changed: transmission, timing, severity, available treatment, developmental injury, maternal injury, or another measurable outcome.

G.S. 90-21.12 states North Carolina's professional standard-of-care framework. Rule 9(j) generally requires qualified review of the available care and records before a medical-malpractice complaint alleging failure to meet that standard is filed.

Place infection evidence in the broader birth record

The related North Carolina birth-injury evidence guide explains how prenatal, labor, delivery, newborn, diagnosis, and developmental records fit into the broader causation review. This page keeps the narrower infection, screening, result, and response task.

Rosensteel Fleishman Car Accident & Injury Lawyers provides information about consulting a medical malpractice attorney in Charlotte for a perinatal infection injury when screening, test communication, maternal care, delivery, or newborn response may have caused additional harm.

Sources